Oura's IPO Filing Signals Push to Monetize Hardware Momentum
AI-generated image · US National Wire
With revenue scaling toward $2 billion, the smart ring maker is seeking a $16 billion valuation as it attempts to pivot from a fitness tracker to a clinical health intelligence platform.
Oura's decision to move toward a public offering suggests a strategic effort to capitalize on rapid hardware adoption before the wearable market reaches a saturation point. As TechCrunch first reported, a Securities and Exchange Commission filing shows the Finnish company has seen its revenue climb from $697 million in the nine-month period ending June 30 of last year to $1.2 billion over the same period this year.
The growth trajectory is aggressive. TechCrunch reports that Oura generated $500 million in revenue in 2024 and approximately $1 billion in 2025, with projections for the current year approaching $2 billion. This financial surge is underpinned by the sale of 3.6 million rings over the past year, with hardware priced between $350 and $400.
From a deals perspective, the timing of the IPO reflects a significant jump in perceived value. Bloomberg previously reported that Oura is expected to seek a $16 billion valuation, a notable increase from the $11 billion valuation it held in October of last year. The company is reportedly looking to raise $3 billion in the offering, having confidentially filed for the IPO in May.
However, the hardware alone is rarely a sustainable moat in the wearables sector. Oura is attempting to shift the narrative from a fitness tracker to what it calls an "always-on health intelligence platform." The company currently counts approximately 5 million paid members who subscribe for expanded health metrics, maintaining a weighted-average 12-month membership retention rate of roughly 85%.
In its SEC filing, Oura explicitly states that its growth opportunities extend beyond traditional activity and fitness tracking. The company aims to expand its reach by deepening integrations with employers, care providers, and health plans, while continuing to build clinical evidence to support larger populations.
Central to this pivot is the monetization of data. Oura claims to possess one of the largest longitudinal biometric datasets in consumer health, encompassing nearly 42 billion hours of physiological data across more than 50 metrics. The company asserts that this data powers AI and machine-learning models designed to improve predictive capabilities and personalization as user histories grow.
Despite the growth, Oura faces headwinds regarding the integrity of its data. TechCrunch reports that the company is facing a proposed class action lawsuit alleging that Oura misled users regarding the accuracy of its sleep tracking. The suit claims the rings cannot detect the necessary physiological signals for sleep stages and instead use AI-generated estimates. Oura has disputed these claims and told TechCrunch it intends to defend itself in the appropriate legal forum.